Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Aeovian brings in $37mm through Series A financing

Executive Summary

VenBio Partners and Sofinnova Investments led a $37mm Series A financing for Aeovian Pharmaceuticals Inc. (targeting the mTORC1 pathway to treat rare and age-related diseases). Returning backers Apollo Health Ventures and Evotec SE also joined. VenBio and Sofinnova will contribute new board members and observers.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register